Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic review

The benefit of chemotherapy for older patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer (EBC) is a key area of debate. Gene expression profiling (GEP) may identify patients deriving benefit, but their predictive role has not be...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) 2022-09, Vol.172, p.158-170
Hauptverfasser:	Battisti, Nicolò Matteo Luca, De Glas, Nienke, Soto-Perez-de-Celis, Enrique, Liposits, Gabor, Bringuier, Michael, Walko, Christine, Lichtman, Stuart M., Aapro, Matti, Cheung, Kwok-Leung, Biganzoli, Laura, Ring, Alistair, Portielje, Johanneke, Wildiers, Hans, Brain, Etienne
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Aged Anthracycline Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - genetics Breast Neoplasms - metabolism Chemotherapy Chemotherapy, Adjuvant Early breast cancer Epidermal growth factor ErbB-2 protein Female Gene expression Gene expression profile Gene Expression Profiling Growth factors Humans Luminal Medical prognosis Older Older people Patients Prognosis Prospective Studies Receptor, ErbB-2 - genetics Receptor, ErbB-2 - metabolism Receptors Retrospective Studies Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!